Biocompatibility Parameters with Standard and Increased Dose of Citrate in Hemodialysis—A Randomized Trial

Background: The dose of citrate needed in regional citrate anticoagulation (RCA) to achieve optimal biocompatibility is unknown. We performed a randomized trial comparing two doses (ACTRN12613001340729). Methods: In 30 patients a single hemodialysis with either standard (2.7 mmol/L) or increased dos...

Descripción completa

Detalles Bibliográficos
Autores principales: Orsag, Alesa, Bozic-Mijovski, Mojca, Hudoklin, Samo, Simcic, Sasa, Gubensek, Jakob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268353/
https://www.ncbi.nlm.nih.gov/pubmed/34279471
http://dx.doi.org/10.3390/jcm10132987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268353/
https://www.ncbi.nlm.nih.gov/pubmed/34279471
http://dx.doi.org/10.3390/jcm10132987

Ejemplares similares